文章摘要
杨建红,陈宁,张冉,赵芬,杜逸,沈梦娟,王璐,宋佳阳,陈震.我国非处方药上市路径调研与结果分析[J].中国药事,2020,34(11):1255-1268
我国非处方药上市路径调研与结果分析
Investigation and Result Analysis of the Marketing Paths of OTC Drug in China
  
DOI：10.16153/j.1002-7777.2020.11.003
中文关键词: 非处方药  上市路径  非处方药专论  药品分类转换  药品注册
英文关键词: over-the-counter drug  marketing path  OTC monograph  drug classification switch  drug registration
基金项目:
作者单位
杨建红 沈阳药科大学亦弘商学院,北京 100055 
陈宁 郑州大学药学院,郑州 450001 
张冉 天境生物科技(上海)有限公司,北京 100010 
赵芬 人福普克(武汉)有限公司,武汉 430000 
杜逸 武田药品(中国)投资有限公司,上海 200040 
沈梦娟 郑州大学药学院,郑州 450001 
王璐 艾昆纬企业管理咨询(上海)有限公司,上海 200041 
宋佳阳 沈阳药科大学亦弘商学院,北京 100055 
陈震 沈阳药科大学亦弘商学院,北京 100055 ；郑州大学药学院,郑州 450001 
摘要点击次数: 516
全文下载次数: 194
中文摘要:
      目的： 对我国非处方药上市路径的现状、存在的问题，以及国外非处方药上市路径管理模式对我国的适用性进行调研。方法：在前期文献研究的基础上，开展问卷调查，并对调查结果进行分析。采用非概率抽样法，选择从事化学药品 OTC 研发、注册、生产、经营的专业人员以及行业协会、监管机构的专家作为调研对象，以微信方式发放电子问卷进行调查。结果：调查结果表明，多数调查对象认为我国应建立符合我国国情的非处方药的专论制度，应完善我国处方药和非处方药的转换标准和程序以及非处方药的注册路径和审评程序。结论：本调研为进一步分析我国在非处方药上市准入管理方面存在的问题及完善建议提供了数据支持。
英文摘要:
      Objective: To investigate the current status and existing problems of OTC drug marketing paths in China, and the applicability of foreign OTC drug marketing path management models to China. Methods: On the basis of previous literature research, a questionnaire survey was conducted and the survey results were analyzed. The non-probability sampling method was used by selecting professionals engaging in chemical OTC drug R&D, registration, production and operation, as well as experts from industry associations and regulatory agencies being the respondents, and questionnaire surveys were conducted by issuing electronic questionnaires through WeChat. Results: The survey results showed that most respondents believed that China should establish OTC monograph system in line with China's national conditions. The standards and procedures for the conversion of prescription drugs and OTC drugs as well as the registration path and review procedures of OTC drugs should be improved in China. Conclusion: This survey provides data support for further analysis of the problems in Chinese OTC drug market access management and suggestions for improvement.
查看全文   查看/发表评论  下载PDF阅读器
关闭